Med Holdings Group Inc. has entered advanced negotiations with nationally recognized urology and sexual wellness specialist Dr. Harvey Samowitz, a strategic move designed to strengthen the company's clinical leadership during a period of rapid expansion. Dr. Samowitz brings more than three decades of experience in urology, sexual medicine, and pelvic health, with board certification from the American Board of Urology and subspecialty certification in Female Pelvic Medicine and Reconstructive Surgery.
Chief Executive Officer Jessica Miller described this development as a defining moment for the company, emphasizing a strategy focused on aligning with elite medical leadership while scaling into high-demand markets. The potential involvement of Dr. Samowitz reflects the caliber of professionals Med Holdings Group is bringing into its ecosystem as it positions for sustained growth and shareholder value creation. Dr. Samowitz maintains affiliations with several prominent medical organizations, including the American Urological Association, American College of Surgeons, and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction.
Concurrent with these negotiations, Med Holdings Group is actively expanding into high-growth markets with negotiations underway for two additional Florida locations in Jupiter and Doral. These markets align directly with the company's demographic strategy targeting high-income populations, with management anticipating these additions will materially strengthen recurring revenue and regional brand dominance. This geographic expansion represents a calculated move to capture market share in affluent regions with demonstrated demand for specialized medical services.
The company is simultaneously accelerating completion of its audit process while advancing its FINRA name change and ticker symbol change, steps intended to enhance transparency, strengthen corporate alignment, and increase market visibility as operations scale. These compliance milestones represent critical infrastructure development for a growing healthcare platform seeking to establish credibility with both investors and patients in a competitive medical landscape.
Med Holdings Group has officially launched its enhanced national platform at TotallBody.com, significantly expanding its addressable market beyond physical locations. The digital platform provides immediate national brand exposure, access to a large underserved U.S. market, and scalable digital engagement for services and future vertical expansion. Management views this as a foundational step toward building a nationally scalable healthcare platform that transcends geographic limitations.
Market momentum appears to support the company's strategic direction, with the stock appreciating more than 500% over the past twelve months and market capitalization now exceeding $3 million. This growth reflects increasing investor awareness and recognition of the company's strategic execution across multiple fronts. With committed expansion capital, a clear acquisition and multi-location rollout strategy, accelerating compliance milestones, expanding clinical leadership, and a scalable national digital infrastructure, Med Holdings Group believes it is strategically positioned for continued operational and market growth into 2026 and beyond.
The implications of this multi-faceted expansion strategy extend beyond corporate growth to potentially reshape patient access to specialized urological and sexual wellness services. By combining elite clinical expertise with geographic expansion and digital scalability, Med Holdings Group is creating an integrated healthcare delivery model that could serve as a template for specialty medical practices seeking national reach. The company's approach addresses several contemporary healthcare challenges, including geographic disparities in access to specialized care and the growing demand for digital health solutions that complement traditional clinical settings.
